Latest posts tagged with #CFResearch on Bluesky
Lung health in people with cystic fibrosis varies across the U.S. New research from our experts shows community deprivation and environmental factors are strongly linked to lung function. Read more: https://ow.ly/tWNz50YooeV
#CysticFibrosis #HealthEquity #CFResearch
Graphic titled "New in the CF News" highlights a study showing severe CF flareups cause temporary pulmonary hypertension in 1 in 4 kids. Age and inflammation linked to PH risk in children with CF. Source: Cystic Fibrosis News Today.
CF Research Update: https://bit.ly/4ru3mLM
A new study reports that one in four children hospitalized with severe cystic fibrosis flareups experienced temporary pulmonary hypertension.
#CysticFibrosis #CysticFibrosisNewsToday #Bionews #CFResearch #PulmonaryHealth
The Latest CF News: CF treatment Trikafta boosts lung function for patients over 40, a study found. Cystic Fibrosis - News Today.
See what this study found: https://bit.ly/45xNKOU
New research suggests Trikafta improved lung function and reduced flare ups in people with cystic fibrosis who started treatment after age 40.
#CysticFibrosis #CysticFibrosisNewsToday #Bionews #CFResearch #CFCommunity #RareDiseaseNews #CFTreatment
The Latest CF News: CMTX-101 therapy helps clear bacterial lung infections, well tolerated in early trial.
Research to watch: https://bit.ly/4szOltb
An experimental antibody therapy is being studied for its potential to help clear stubborn lung infections in cystic fibrosis.
#CysticFibrosis #CFResearch #ClinicalTrials #LungHealth #CFScience #RareDiseaseResearch #CysticFibrosisNewsToday #Bionews
Headline: CF NEWS on CFTR mutations; study links them to CF-related diabetes (CFRD) by impairing pancreatic function, apart from mucus buildup.
Learn what this means: https://bit.ly/49eXmQZ
New research suggests CFTR mutations may contribute to CF related diabetes by directly affecting how the pancreas works, not just through mucus related damage.
#CysticFibrosis #CysticFibrosisNewsToday #CFResearch #CFDiabetes #CFRD #Bionews
New study shows lung MRIs outperform breathing tests in predicting cystic fibrosis exacerbations.
Looking beyond breathing tests: https://bit.ly/4aKfXpb
New research suggests specialized lung MRI scans may do a better job than standard breathing tests at predicting flare-ups in people with cystic fibrosis.
#CysticFibrosis #CFNews #CysticFibrosisNewsToday #Bionews #CFResearch #LungHealth
Collision repair group raises over $6 million for cystic fibrosis research, care, and advocacy.
Community support in action: https://bit.ly/4prYrd4
More than $6 million has been raised to support cystic fibrosis research, care, and advocacy.
#CysticFibrosis #CysticFibrosisNewsToday #CFAwareness #CFResearch #RareDisease #HealthNews #MedicalResearch #Bionews
Headline: New GLP-1 receptor agonists boost lung function in CF patients. Source: CysticFibrosisNewsToday.com.
New CF research insight: https://bit.ly/3L6ab6L
A study suggests GLP-1 medications, commonly used for diabetes and weight management, may improve lung function in some people with cystic fibrosis, even as weight decreases.
#CysticFibrosis #CysticFibrosisNewsToday #CFResearch #Bionews
P. aeruginosa intrastrain diversity drastically changes its spatial organization in lung infections. OSA-deficient variants, common in CF/COPD, surprisingly led to larger bacterial aggregates in vivo. #Microbiology #CFResearch journals.asm.org/doi/10.1128/...
Blue background with a megaphone graphic. Text highlights that ETD001, an inhaled therapy, is well tolerated and remains longer in lungs.
New CF therapy update: https://bit.ly/44t9HhF
An inhaled investigational treatment showed encouraging safety results in a Phase 1 trial and remained in the lungs longer than expected.
#CysticFibrosis #CFResearch #ClinicalTrials #RareDiseaseResearch #CFNews #CysticFibrosisNewsToday #Bionews
Generic antibiotic for CF lung infections gains FDA approval, overlaid on an illustration of lungs and bacteria.
Celebrate Affordable Access: https://bit.ly/4qHM0LI
A new FDA approval is making treatment more affordable for people with cystic fibrosis.
#CysticFibrosisNews #CFCommunity #Tobramycin #CFResearch #CysticFibrosis #CFWarrior #CFStrong #Bionews #RareDiseaseCommunity
Infographic explaining class 1 mutations in protein production: nonsense mutations lead to incomplete CFTR protein; splicing mutations prevent CFTR production.
Understand class 1 mutations: https://bit.ly/4oDWOJj
Protein production, or class 1, mutations stop the CFTR protein from being made. These include nonsense and splicing mutations, found in about 10% of people with cystic fibrosis.
#CysticFibrosis #CFResearch #CysticFibrosisNewsToday #Bionews
FYI: LucidQuest Views >>> Respiratory Weekly News – July 18th 2025 #News #AIinBiotech #CFResearch #COPDTreatment Comment below!
ICYMI: LucidQuest Views >>> Respiratory Weekly News – July 18th 2025 #News #AIinBiotech #CFResearch #COPDTreatment Comment below!
LucidQuest Views >>> Respiratory Weekly News – July 18th 2025 #News #AIinBiotech #CFResearch #COPDTreatment Comment below!
Drs. Nadim Srour and Shawn Aaron (@ottawahospital.bsky.social)'s study on impact of infection with transmissible strains of Pseudomonas aeruginosa on lung transplantation outcomes in patients with cystic fibrosis: www.psifoundation.org/funded-resea.... #CFAwarenessMonth #CFResearch
Dr. Neil Goldberg and John Laffey (@unityhealthto.bsky.social)'s study on the role of #CysticFibrosis transmembrane conductance regulator and transient receptor potential channels in hypoxic pulmonary vasoconstriction: www.psifoundation.org/funded-resea.... #CFAwarenessMonth #CFResearch
Drs. Cory Masaru Yamashita and Ruud Veldhuizen (@ruudveldhuizen.bsky.social) (@schulichmeddent.bsky.social)'s study on antimicrobial peptide fortified surfactant for the treatment of #CysticFibrosis: www.psifoundation.org/funded-resea.... #CFAwarenessMonth #CFResearch
May is #CysticFibrosis Awareness Month.
PSI funds grantees who are advancing research to improve outcomes for people living with #CysticFibrosis in Ontario and beyond.
Check out our grantees' studies:
#CFAwarenessMonth #CFResearch
A study in Ohio revealed that treatment with Trikafta effectively improves lung function & nutrition status in adults and adolescents with CF, with particularly positive benefits for those with more severe lung disease. #CFresearch
Read More: www.sciencedirect.com/science/arti...
Recognizing the diversity of experiences in CF is crucial for developing personalized, person-centric, equitable care strategies. Let's optimize care for all pwCF! #CysticFibrosis #HealthcareEquity #HealthEquity #CFResearch #HealthcareAccess
📢 #PhD Opportunity 3! Investigate how the airway microbiome shapes pulmonary exacerbations in pwCF. Join us @qubelfastofficial.bsky.social to uncover the links between microbial dynamics and clinical outcomes. 🧬🌬️ Apply here: tinyurl.com/2bmm3yqn
#PhD #Microbiome #CF #CFResearch #PULSECF
#PhD Opportunity 2! Explore enhanced microbiological surveillance in pwCF. Join @qubelfastofficial.bsky.social cutting-edge PULSE-CF initiative to improve understanding and management of CF-related infections.🌟Learn more & apply: tinyurl.com/27o2purp
#PhD #Microbiology #CF #CFResearch #PULSECF
